Seeking Alpha

CuraGen Corp. (CRGN)

()

Comments on CRGN

  • Curagen: Positive Results at ASCO 2009 [View article]
    Sorry, cannot comment on that.
    Comment by Ohad Hammer
    Jul 13 09:35 am |
    Rating: 0 0
  • Curagen: Positive Results at ASCO 2009 [View article]
    Ohad Hi What is your current opinion on GENZ and it's manufacturing troubles , and what do you think of it's potential competitor... More »
    Comment by bio boy
    Jul 9 10:51 am |
    Rating: 0 0
  • FDA, Clinical Trial Calendars: Cancer Drug Updates from ASCO [View article]
    Also: Access Pharmaceuticals (ACCP.OB) provides an update on ProLindac(TM) Phase 2 Ovarian Cancer Trial : ProLindac Showing High DACH... More »
    Comment by svygear
    Jun 3 11:07 am |
    Rating: 0 0
  • Two Potential Mega Biotech Deals Fuel Industry Hopes [View article]
    http://seekingalpha.com/article/140870-biotech-opportunities-look-for-decent-pipeline-big-pharma-partnerships#comment-528823
    Comment by svygear
    Jun 2 18:21 pm |
    Rating: 0 0
  • Two Potential Mega Biotech Deals Fuel Industry Hopes [View article]
    Fast paced biotech science is rapidly expanding in many areas,especially in the health field. A small canadian company in Nova... More »
    Comment by jerrybruce
    Jun 1 14:05 pm |
    Rating: 0 0
  • FDA, Clinical Trial Calendars: Cancer Drug Updates from ASCO [View article]
    mike, excellent summary as always
    Comment by Beta Delta
    Jun 1 09:25 am |
    Rating: 0 0
  • CuraGen Presents an Opportune Time to Exit [View article]
    Nice synopsis. Today they announced a deal, and hopefully this stock has some further upside from its current $1.35/share.
    Comment by BxCapricorn
    May 29 10:51 am |
    Rating: +1 0
  • Top Biotech Picks for ASCO 2009 (Part II) [View article]
    This is a follow up to my previous post. Genmab will indeed be represented at ASCO. See below: OFATUMUMAB AND R1507 DATA TO BE... More »
    Comment by hpski
    May 28 17:02 pm |
    Rating: 0 0
  • Top Biotech Picks for ASCO 2009 (Part II) [View article]
    This is not an ASCO issue, however ASCO is overshadowing the development reprinted below. I fully expect ODAC to recommend approval.... More »
    Comment by hpski
    May 28 16:47 pm |
    Rating: 0 0
  • Top Biotech Picks for ASCO 2009 (Part I) [View article]
    As I wrote, the list is incomplete. Besides, most of the important data for ALTH's drug is already known and were submitted to the FDA.
    Comment by Ohad Hammer
    May 27 15:23 pm |
    Rating: 0 0
  • Top Biotech Picks for ASCO 2009 (Part I) [View article]
    Why is there no mention of ALTH ?
    Comment by Jonha's Pop
    May 27 11:52 am |
    Rating: 0 0
  • Clinical Trial Updates: Cancer Drugs in Focus as ASCO Approaches [View article]
    http://bloggingstocker.blogspot.com/2009/05/3-ultra-cheap-stocks-for-summer-and.html
    Comment by gtmcduffy@gmail.com
    May 18 23:08 pm |
    Rating: 0 0
  • Performance and Update of Our Undervalued Assets Portfolio [View article]
    I'm really curious about what it is that Alpha sees good about Autobytel. Especially considering the fact that the automobile industry... More »
    Comment by User 339348
    Mar 2 14:28 pm |
    Rating: 0 0
  • Performance and Update of Our Undervalued Assets Portfolio [View article]
    why not a mutual fund or ETF of this idea?
    Comment by oldman
    Mar 2 09:57 am |
    Rating: 0 0
  • 20 Graham and Dodd Net / Nets [View article]
    Great point on DIP financing. This is no time to make the bankruptcy process worse. If the "bailout" were well targeted, it would... More »
    Comment by axelrod608
    Jan 26 16:51 pm |
    Rating: 0 0